In humans, the increase in NT-proBNP after exercise testing has proven crucial in the prognosis and classification of patients with mitral regurgitation, allowing the identification of asymptomatic patients who will develop severe cardiac symptoms (CHF or acute pulmonary edema). The gene discussed is NPPB; the disease is mitral valve insufficiency.